A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

NCT00543569 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Alefacept
DRUG: tacrolimus
DRUG: basiliximab
DRUG: mycophenolate mofetil
DRUG: Corticosteroids

Sponsor

Astellas Pharma Inc